Surterra Wellness welcomes Ed Brown and Kevin Fisher to its Board and announces $100m Series D funding

– USA, GA –  Surterra Wellness, one of the fastest growing health and wellness companies in the United States, today announced the initial closing of a $100 million Series D funding round and the expansion of its Board of Directors.

Surterra plans to use the proceeds to fund strategic acquisitions and infrastructure capital expenditures. Participants in the round include existing and new investors, ultra-high net worth individuals and family investment offices, including former Patrón Spirits Company CEO, Ed Brown.

“This significant financing reflects Surterra’s ability to attract a sophisticated, curated investor group who trust our vision, business model and financial track record. The funding will accelerate our expansion as we add new iconic brands, build out our scalable infrastructure, invest in innovation, and fuel our next stage of growth across the U.S. and global markets,” said Surterra CEO Beau Wrigley.

Surterra welcomes two strategic additions to its Board of Directors, with Ed Brown and Kevin Fisher joining.

“We are thrilled to welcome Ed and Kevin to Surterra’s Board of Directors. Ed’s distinctive expertise in the alcohol, beverage and consumer packaged goods industry and Kevin’s gold-standard cannabis operations and market building experience significantly expand our leadership bench strength. We look forward to their contributions as strategic members of both our executive team and Board of Directors as we accelerate our stride to become a leading global cannabis health and wellness company,” said Wrigley.

Surterra has raised over $300 million in private capital to date. The Series D funding follows a period of rapid growth for Surterra over the past few months, which has transformed the company into a multi-state cannabis health and wellness business operator with recognizable brands, a revenue-generating business strategy, and meaningful investments in people, science, technology, and innovation.

About Ed Brown

Ed Brown, Executive Director, Surterra, previously served as the President and CEO of The Patrón Spirits Company, until retiring last year after nearly 20 years at the company. Under his leadership, Patrón grew from 118,000 cases sold in 2001 to more than 4.1 million in 2016 and is currently the top-selling ultra-premium tequila in the world. Brown will apply his expertise in the premier spirits business to Surterra’s strategic global brand building, marketing, and sales execution.

About Kevin Fisher

Kevin Fisher, Executive Director of Operations, Surterra, is a cannabis industry pioneer, and co-founder and former CEO of both New England Treatment Access, a premier, a vertically integrated cannabis company in Massachusetts, and Molecular Infusions, a world-class, cannabinoid-focused, biopharmaceutical company based in Boston. Surterra recently acquired both companies. Fisher will bring his leadership and operational expertise in regulated medical and adult-use cannabis to Surterra.

About Surterra Wellness

Surterra Wellness is one of the nation’s fastest growing health and wellness companies. With vertical operations in Florida, Texas, Nevada, and Massachusetts, Surterra brings a broad portfolio of high-quality brands to meet the needs of individuals who choose the natural medical relief and wellness enhancing benefits of cannabis products. Surterra offers a wide variety of medical, health and wellness products in multiple delivery options, including vaporizer pens, tinctures, oral sprays, topical creams, time released transdermal patches, and soft gels. The company’s brand portfolio includes Surterra Wellness, Florida’s Finest, The Apothecary Shoppe, and Coral Reefer. Founded in 2014, Surterra serves thousands of consumers each year.

For more information: https://www.surterra.com

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Comments are closed.